Phase IIa study of fenretinide in superficial bladder cancer, using DNA flow cytometry as an intermediate end point

Andrea Decensi, Silvia Bruno, Massimo Costantini, Rosalba Torrisi, Antonio Curotto, Beatrice Gatteschi, Guido Nicolò, Anna Polizzi, Marjorie Perloff, Winfred F. Malone, Paolo Bruzzi

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)138-140
Number of pages3
JournalJournal of the National Cancer Institute
Volume86
Issue number2
Publication statusPublished - Jan 19 1994

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Physiology (medical)
  • Radiology Nuclear Medicine and imaging

Cite this

Decensi, A., Bruno, S., Costantini, M., Torrisi, R., Curotto, A., Gatteschi, B., Nicolò, G., Polizzi, A., Perloff, M., Malone, W. F., & Bruzzi, P. (1994). Phase IIa study of fenretinide in superficial bladder cancer, using DNA flow cytometry as an intermediate end point. Journal of the National Cancer Institute, 86(2), 138-140.